What is the mechanism of action for Anipryl (selegiline hydrochloride) in treating CCDS?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Prepare for the Primary Care II Senior Dog Care Exam. Utilize flashcards and multiple-choice questions with hints and explanations to ensure you're ready for your test!

Multiple Choice

What is the mechanism of action for Anipryl (selegiline hydrochloride) in treating CCDS?

Explanation:
Anipryl works by inhibiting monoamine oxidase B in the brain. MAO-B's job is to break down dopamine, so blocking this enzyme increases dopamine availability in dopaminergic pathways. In Canine Cognitive Dysfunction Syndrome, boosting dopamine helps improve cognition and activity, making this mechanism particularly effective. At therapeutic doses, the drug is relatively selective for MAO-B, which means it mainly enhances dopamine with fewer issues related to other monoamines. The other options relate to different targets (acetylcholine, glutamate, or amyloid processing) and do not describe how Anipryl works.

Anipryl works by inhibiting monoamine oxidase B in the brain. MAO-B's job is to break down dopamine, so blocking this enzyme increases dopamine availability in dopaminergic pathways. In Canine Cognitive Dysfunction Syndrome, boosting dopamine helps improve cognition and activity, making this mechanism particularly effective. At therapeutic doses, the drug is relatively selective for MAO-B, which means it mainly enhances dopamine with fewer issues related to other monoamines. The other options relate to different targets (acetylcholine, glutamate, or amyloid processing) and do not describe how Anipryl works.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy